Log in

Relevant bibliographies by topics / Inhibitors / Books

To see the other types of publications on this topic, follow the link: Inhibitors.

Books on the topic 'Inhibitors'

Author: Grafiati

Published: 4 June 2021

Last updated: 1 February 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Inhibitors.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Iqbal, Choudhary Muhammad, ed. Biological inhibitors. Amsterdam: Harwood Academic Publishers, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Zollner, Helmward. Handbook of enzyme inhibitors. 2nd ed. Weinheim, Federal Republic of Germany: VCH, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

Zollner, Helmward. Handbook of enzyme inhibitors. 3rd ed. Weinheim: New York, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Zollner, Helmward. Handbook of enzyme inhibitors. Weinheim, Federal Republic of Germany: VCH, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Laufer, Stefan, ed. Proteinkinase Inhibitors. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-68180-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

D’Orléans-Juste, Pedro, and Gérard E. Plante, eds. ACE Inhibitors. Basel: Birkhäuser Basel, 2001. http://dx.doi.org/10.1007/978-3-0348-7579-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Kuster, Bernhard, ed. Kinase Inhibitors. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-61779-337-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Furr, Barrington J. A., ed. Aromatase Inhibitors. Basel: Birkhäuser Basel, 2006. http://dx.doi.org/10.1007/3-7643-7418-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Furr, Barrington J. A., ed. Aromatase Inhibitors. Basel: Birkhäuser Basel, 2008. http://dx.doi.org/10.1007/978-3-7643-8693-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Hayes, Teresa L. Corrosion inhibitors. Cleveland, Ohio: Freedonia Group, 2002.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

11

A, Furr B. J., ed. Aromatase inhibitors. Basel: Birkhäuser, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

12

1928-, Laskin Allen I., and Lechevalier Hubert A, eds. Antimicrobial inhibitors. 2nd ed. Boca Raton, Fla: CRC Press, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

13

Innes, George L. Corrosion inhibitors. Norwalk, CT: Business Communications Co., 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

14

Donald, Saxman, and Business Communications Co, eds. Corrosion inhibitors. Norwalk, CT: Business Communications Co., 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

15

Baumgartner, William G. Corrosion inhibitors. Cleveland, Ohio: Freedonia Group, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

16

J, Barrett Alan, and Salvesen G, eds. Proteinase inhibitors. Amsterdam: Elsevier, 1986.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

17

1957-, D'Orléans-Juste P., and Plante G. E, eds. ACE inhibitors. Basel: Birkhäuser Verlag, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

18

Jiang, Shibo, and Lu Lu, eds. Virus Entry Inhibitors. Singapore: Springer Singapore, 2022. http://dx.doi.org/10.1007/978-981-16-8702-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Gupta, Satya Prakash, ed. Matrix Metalloproteinase Inhibitors. Basel: Springer Basel, 2012. http://dx.doi.org/10.1007/978-3-0348-0364-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Mellinghoff, Ingo K., and Charles L. Sawyers, eds. Therapeutic Kinase Inhibitors. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-28296-6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Higgs, Gerry A., and Brian Henderson, eds. Novel Cytokine Inhibitors. Basel: Birkhäuser Basel, 2000. http://dx.doi.org/10.1007/978-3-0348-8450-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Sastri, V. S. Green Corrosion Inhibitors. Hoboken, NJ, USA: John Wiley & Sons, Inc., 2011. http://dx.doi.org/10.1002/9781118015438.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Weinberg, Jeffrey M., and Robin Buchholz, eds. TNF-alpha Inhibitors. Basel: Birkhäuser-Verlag, 2006. http://dx.doi.org/10.1007/3-7643-7438-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Pairet, Michel, and Joanne van Ryn, eds. COX-2 Inhibitors. Basel: Birkhäuser Basel, 2004. http://dx.doi.org/10.1007/978-3-0348-7879-1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Supuran, Claudiu T., and Clemente Capasso, eds. Zinc Enzyme Inhibitors. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-46112-0.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Hjalmarson, Å., and W. J. Remme, eds. Sinus node inhibitors. Heidelberg: Steinkopff, 1991. http://dx.doi.org/10.1007/978-3-642-72458-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Olbe, Lars, ed. Proton Pump Inhibitors. Basel: Birkhäuser Basel, 1999. http://dx.doi.org/10.1007/978-3-0348-8795-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Lars, Olbe, ed. Proton pump inhibitors. Basel: Birkhauser, 1999.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

29

S, Stokes G., Marwood J. F. 1946-, and International Congress of Pharmacology (10th : 1987 : Sydney, N.S.W.), eds. Sodium transport inhibitors. Basel: Karger, 1988.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

30

name, No. HMG-CoA reductase inhibitors. Basel: Birkhuser Verlag, 2003.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

31

McAlpine, Shelli R., and Adrienne Lesley Edkins, eds. Heat Shock Protein Inhibitors. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-32607-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Warner, Timothy D., ed. Endothelin and Its Inhibitors. Berlin, Heidelberg: Springer Berlin Heidelberg, 2001. http://dx.doi.org/10.1007/978-3-642-56899-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Page, Clive, Christian Schudt, Gordon Dent, and Klaus F. Rabe. Phosphodiesterase Inhibitors. Elsevier Science & Technology Books, 1996.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

34

Inamuddin, ed. Sustainable Corrosion Inhibitors. Materials Research Forum LLC, 2021. http://dx.doi.org/10.21741/9781644901496.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Fleischmann, Roy. Signalling pathway inhibitors. Oxford University Press, 2013. http://dx.doi.org/10.1093/med/9780199642489.003.0081.

Full text

Abstract:

Oral, small-molecule signalling pathway inhibitors, including ones that inhibit the JAK and SyK pathways, are currently in development for the treatment of rheumatoid arthritis (RA). Tofacitinib is an orally administered small-molecule inhibitor that targets the intracellular Janus kinase 3 and 1 (JAK1/3) molecules to a greater extent than JAK2 while baricitinib (formerly INCB028050) predominantly inhibits JAK1/2. Many of the proinflammatory cytokines implicated in the pathogenesis of RA utilize cell signalling that involves the JAK-STAT pathways and therefore inhibition of JAK-STAT signalling, by targeting multiple RA-associated cytokine pathways, has the potential to simultaneously reduce inflammation, cellular activation, and proliferation of key immune cells. Fostamatinib disodium is an orally available inhibitor of spleen tyrosine kinase (SyK), which is a cytoplasmic tyrosine kinase that is an important mediator of immunoreceptor signalling in mast cells, macrophages, neutrophils, and B cells. Interruption of SyK signalling may interrupt production of tumour necrosis factor (TNF) and metalloproteinase and therefore affect RA disease activity. Tofacitinib has been investigated in multiple phase 2 and phase 3 trials which have investigated its efficacy (clinical, functional, and radiographic) and safety in patients who have failed disease-modifying anti-inflammatory drugs (DMARDs) as monotherapy or in combination with DMARDs, compared to an inhibitor of tumour necrosis factor alpha (TNFα‎) and in patients who have failed TNFα‎ inhibitors. The efficacy of fostamatinib and baricitinib has been investigated in phase 2 trials; both are in large phase 3 clinical programmes. Each of these medications has demonstrated efficacy; their safety profile has been shown to be different from each other and from currently approved biological agents. This chapter discusses what is currently known and understood about their efficacy and safety.

APA, Harvard, Vancouver, ISO, and other styles

36

Choudhary, M. Iqbal. Biological Inhibitors. Taylor & Francis Group, 2020.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

37

Brodie, Angela, J. Michael Dixon, Robert Paridaens, Miller William R, and B. J. A. Furr. Aromatase Inhibitors. Springer London, Limited, 2006.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

38

Fantacuzzi, Marialuigia, and Alessandra Ammazzalorso, eds. Anticancer Inhibitors. MDPI, 2022. http://dx.doi.org/10.3390/books978-3-0365-4919-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Phosphodiesterase Inhibitors. Elsevier, 1996. http://dx.doi.org/10.1016/b978-0-12-210720-7.x5000-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Singh, Ambrish, ed. Corrosion Inhibitors. IntechOpen, 2019. http://dx.doi.org/10.5772/intechopen.76742.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Savino, Rocco. Cytokine Inhibitors. CRC Press LLC, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

42

Singh, Ambrish. Corrosion Inhibitors. IntechOpen, 2019.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

43

D'Orleans-Juste, Pedro. Ace Inhibitors. Island Press, 2001.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

44

D'Orléans-Juste, Pedro, and G. E. Plante. ACE Inhibitors. Birkhauser Verlag, 2012.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

45

Ciliberto, Gennaro. Cytokine Inhibitors. Taylor & Francis Group, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

46

Ciliberto, Gennaro. Cytokine Inhibitors. Taylor & Francis Group, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

47

GOUDOT. Metabolic Inhibitors. John Wiley & Sons Inc, 1993.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

48

Laufer, Stefan. Proteinkinase Inhibitors. Springer International Publishing AG, 2021.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

49

Corrosion Inhibitors. NACE International: The Corrosion Society, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

50

Ciliberto, Gennaro. Cytokine Inhibitors. Taylor & Francis Group, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!